S
Stefan Laufer
Researcher at University of Tübingen
Publications - 517
Citations - 13336
Stefan Laufer is an academic researcher from University of Tübingen. The author has contributed to research in topics: Kinase & Chemistry. The author has an hindex of 59, co-authored 481 publications receiving 11158 citations. Previous affiliations of Stefan Laufer include Benemérita Universidad Autónoma de Puebla & University of Mainz.
Papers
More filters
Journal ArticleDOI
Candidate drugs against SARS-CoV-2 and COVID-19.
TL;DR: There exists a number of candidate drugs that may inhibit infection with and replication of SARS-CoV-2, and chloroquine and hydroxychloroquine, and off-label antiviral drugs, such as the nucleotide analogue remdesivir, HIV protease inhibitors lopinavir and ritonavir, broad-spectrum antiviral Drugs arbidol and favipiravir as well as antiviral phytochemicals available to date may prevent spread.
Journal ArticleDOI
Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology
Matthias Gehringer,Stefan Laufer +1 more
TL;DR: An overview of warheads-beyond α,β-unsaturated amides-recently used in the design of targeted covalent ligands is provided, with special emphasis on the discussion of reactivity and of case studies illustrating applications in medicinal chemistry and chemical biology.
Journal ArticleDOI
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
Oliver Borst,Britta Walker,Patrick Münzer,Antonella Russo,Evi Schmid,Caterina Faggio,Boris Bigalke,Stefan Laufer,Meinrad Gawaz,Florian Lang +9 more
TL;DR: Skepinone-L did not impair platelet Ca2+ signaling but prevented agonist-induced thromboxane A2 synthesis through abrogation of p38 MAPK-dependent phosphorylation of platelet cytosolic phospholipase A2 (cPLA2).
Journal ArticleDOI
Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts.
TL;DR: The scratch assay in the present form can be used as a promising scientific approach and platform to differentiate between plant extracts known for their wound healing and their anti-inflammatory properties.
Journal ArticleDOI
In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
Ramona Rudalska,Daniel Dauch,Thomas Longerich,Katherine McJunkin,Torsten Wuestefeld,Tae-Won Kang,Anja Hohmeyer,Marina Pesic,Josef Leibold,Anne von Thun,Peter Schirmacher,Johannes Zuber,Karl-Heinz Weiss,Scott Powers,Nisar P. Malek,Martin Eilers,Bence Sipos,Scott W. Lowe,Robert Geffers,Stefan Laufer,Lars Zender +20 more
TL;DR: A system that enables pooled shRNA screening directly in mouse hepatocellular carcinomas in vivo to identify genes likely to be involved in therapy resistance is described, suggesting that a combination of sorafenib and Mapk14 blockade is a promising approach to overcoming therapy resistance of human HCC.